淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4807人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997893, encodeId=f92b199e8934e, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：在慢性淋巴细胞白血病中，Wnt5a诱导ROR1招募DOCK2激活Rac1/2，从而增强CLL细胞增殖, objectType=article, longId=136097, objectId=b55613609ee3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b55613609ee3, replyNumber=0, likeNumber=58, createdTime=2018-07-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b55613609ee3, moduleTitle=Blood：在慢性淋巴细胞白血病中，Wnt5a诱导ROR1招募DOCK2激活Rac1/2，从而增强CLL细胞增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b55613609ee3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997870, encodeId=2d25199e870f0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet haemat：利妥昔单抗用于化疗诱导缓解的慢性淋巴细胞白血病老年患者的维持治疗的效果和安全性。, objectType=article, longId=124145, objectId=d43c12414522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d43c12414522, replyNumber=0, likeNumber=58, createdTime=2018-08-10, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d43c12414522, moduleTitle=Lancet haemat：利妥昔单抗用于化疗诱导缓解的慢性淋巴细胞白血病老年患者的维持治疗的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d43c12414522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997871, encodeId=2085199e871ec, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！, objectType=article, longId=125530, objectId=ba02125530b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba02125530b8, replyNumber=0, likeNumber=120, createdTime=2018-07-02, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba02125530b8, moduleTitle=Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba02125530b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997911, encodeId=3e7c199e91102, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2018 多学科意见书：慢性淋巴细胞白血病和滤泡性淋巴瘤应用艾代拉利司治疗相关不良事件的管理, objectType=article, longId=148933, objectId=8f99148933a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f99148933a1, replyNumber=0, likeNumber=18, createdTime=2018-12-20, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f99148933a1, moduleTitle=2018 多学科意见书：慢性淋巴细胞白血病和滤泡性淋巴瘤应用艾代拉利司治疗相关不良事件的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f99148933a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997899, encodeId=1faa199e89962, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=IGLH：CD81和CD58在儿童B淋巴细胞白血病检测中的作用？, objectType=article, longId=139527, objectId=8f3f13952ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f3f13952ebf, replyNumber=0, likeNumber=78, createdTime=2018-08-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f3f13952ebf, moduleTitle=IGLH：CD81和CD58在儿童B淋巴细胞白血病检测中的作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f3f13952ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997909, encodeId=8456199e90928, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：Obinutuzumab、依鲁替尼和venetoclax联合靶向疗法用于慢性淋巴细胞白血病的1b期研究结果, objectType=article, longId=146853, objectId=ab0514685311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab0514685311, replyNumber=0, likeNumber=69, createdTime=2018-12-03, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab0514685311, moduleTitle=Blood：Obinutuzumab、依鲁替尼和venetoclax联合靶向疗法用于慢性淋巴细胞白血病的1b期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab0514685311)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997868, encodeId=5352199e868ff, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT, objectType=article, longId=123311, objectId=ff8a12331154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff8a12331154, replyNumber=0, likeNumber=20, createdTime=2018-11-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff8a12331154, moduleTitle=【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff8a12331154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997908, encodeId=62fe199e908b3, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V1）, objectType=article, longId=146527, objectId=57c714652efd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57c714652efd, replyNumber=0, likeNumber=21, createdTime=2019-01-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57c714652efd, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57c714652efd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997874, encodeId=45a5199e87423, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：CK1δ/ε抑制剂，PF-670462，治疗慢性淋巴细胞白血病的效果。, objectType=article, longId=126564, objectId=57f0126564cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f0126564cc, replyNumber=0, likeNumber=56, createdTime=2018-06-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f0126564cc, moduleTitle=Blood：CK1δ/ε抑制剂，PF-670462，治疗慢性淋巴细胞白血病的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f0126564cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997856, encodeId=49bc199e85688, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=急性T淋巴细胞白血病与工作中接触哪种毒物有关？, objectType=article, longId=117408, objectId=83c811e4087d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83c811e4087d, replyNumber=0, likeNumber=103, createdTime=2018-08-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83c811e4087d, moduleTitle=急性T淋巴细胞白血病与工作中接触哪种毒物有关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83c811e4087d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997863, encodeId=4700199e8633a, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【2017 ASH】Venetoclax在复发或难治性del17p突变慢性淋巴细胞白血病临床实践中的效果评估, objectType=article, longId=122544, objectId=343112254479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=343112254479, replyNumber=0, likeNumber=59, createdTime=2018-06-22, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=343112254479, moduleTitle=【2017 ASH】Venetoclax在复发或难治性del17p突变慢性淋巴细胞白血病临床实践中的效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=343112254479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997880, encodeId=3e1a199e880b6, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：依鲁替尼单药治疗慢性淋巴细胞白血病患者，随访5年的结果, objectType=article, longId=129111, objectId=a59e129111bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a59e129111bf, replyNumber=0, likeNumber=70, createdTime=2018-12-16, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a59e129111bf, moduleTitle=Blood：依鲁替尼单药治疗慢性淋巴细胞白血病患者，随访5年的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a59e129111bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997883, encodeId=7bb0199e88370, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Brit J Cancer：儿童期感染与儿童急性淋巴细胞白血病风险！, objectType=article, longId=131242, objectId=cbd1131242c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbd1131242c3, replyNumber=0, likeNumber=87, createdTime=2018-10-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbd1131242c3, moduleTitle=Brit J Cancer：儿童期感染与儿童急性淋巴细胞白血病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbd1131242c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997857, encodeId=d006199e85789, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2017 日本造血和淋巴组织肿瘤指南：急性淋巴细胞白血病／成淋巴细胞性淋巴瘤, objectType=article, longId=118918, objectId=7da211891852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da211891852, replyNumber=0, likeNumber=19, createdTime=2017-12-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da211891852, moduleTitle=2017 日本造血和淋巴组织肿瘤指南：急性淋巴细胞白血病／成淋巴细胞性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da211891852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997878, encodeId=c991199e87810, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, objectType=article, longId=128476, objectId=1e4c1284e6be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4c1284e6be, replyNumber=0, likeNumber=68, createdTime=2018-10-26, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4c1284e6be, moduleTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4c1284e6be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997887, encodeId=bd5a199e8879c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=初治和复发/难治性慢性淋巴细胞白血病使用伊布替尼单药治疗的5年经验, objectType=article, longId=133936, objectId=36181339363b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36181339363b, replyNumber=0, likeNumber=64, createdTime=2018-05-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36181339363b, moduleTitle=初治和复发/难治性慢性淋巴细胞白血病使用伊布替尼单药治疗的5年经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36181339363b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997882, encodeId=647f199e882ac, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病／小淋巴细胞淋巴瘤（2018.V3）, objectType=article, longId=130270, objectId=905a1302e0f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=905a1302e0f7, replyNumber=0, likeNumber=14, createdTime=2019-02-05, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=905a1302e0f7, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病／小淋巴细胞淋巴瘤（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=905a1302e0f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997907, encodeId=af1f199e9077c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nat Rev Clin Oncol：Nature子刊颁布CAR-T疗法指南，关联儿童急性淋巴细胞白血病, objectType=article, longId=146145, objectId=aacf1461457b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aacf1461457b, replyNumber=0, likeNumber=57, createdTime=2019-06-20, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aacf1461457b, moduleTitle=Nat Rev Clin Oncol：Nature子刊颁布CAR-T疗法指南，关联儿童急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aacf1461457b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997851, encodeId=625d199e85144, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：CTL019在复发性/难治性急性B淋巴细胞白血病和慢性淋巴细胞白血病中的细胞动力学分析。, objectType=article, longId=113754, objectId=931b113e540a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=931b113e540a, replyNumber=0, likeNumber=78, createdTime=2018-04-17, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=931b113e540a, moduleTitle=Blood：CTL019在复发性/难治性急性B淋巴细胞白血病和慢性淋巴细胞白血病中的细胞动力学分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=931b113e540a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997849, encodeId=a108199e84936, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=《中国成人急性淋巴细胞白血病诊断与治疗的指南（2016版）》解读, objectType=article, longId=113393, objectId=4cce11339397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cce11339397, replyNumber=0, likeNumber=19, createdTime=2018-07-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cce11339397, moduleTitle=《中国成人急性淋巴细胞白血病诊断与治疗的指南（2016版）》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cce11339397)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：在慢性淋巴细胞白血病中，Wnt5a诱导ROR1招募DOCK2激活Rac1/2，从而增强CLL细胞增殖

2018-07-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet haemat：利妥昔单抗用于化疗诱导缓解的慢性淋巴细胞白血病老年患者的维持治疗的效果和安全性。

2018-08-10

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！

2018-07-02

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2018 多学科意见书：慢性淋巴细胞白血病和滤泡性淋巴瘤应用艾代拉利司治疗相关不良事件的管理

2018-12-20

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

IGLH：CD81和CD58在儿童B淋巴细胞白血病检测中的作用？

2018-08-01

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：Obinutuzumab、依鲁替尼和venetoclax联合靶向疗法用于慢性淋巴细胞白血病的1b期研究结果

2018-12-03

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT

2018-11-21

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V1）

2019-01-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：CK1δ/ε抑制剂，PF-670462，治疗慢性淋巴细胞白血病的效果。

2018-06-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

急性T淋巴细胞白血病与工作中接触哪种毒物有关？

2018-08-21

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【2017 ASH】Venetoclax在复发或难治性del17p突变慢性淋巴细胞白血病临床实践中的效果评估

2018-06-22

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：依鲁替尼单药治疗慢性淋巴细胞白血病患者，随访5年的结果

2018-12-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Brit J Cancer：儿童期感染与儿童急性淋巴细胞白血病风险！

2018-10-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2017 日本造血和淋巴组织肿瘤指南：急性淋巴细胞白血病／成淋巴细胞性淋巴瘤

2017-12-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病

2018-10-26

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

初治和复发/难治性慢性淋巴细胞白血病使用伊布替尼单药治疗的5年经验

2018-05-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病／小淋巴细胞淋巴瘤（2018.V3）

2019-02-05

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nat Rev Clin Oncol：Nature子刊颁布CAR-T疗法指南，关联儿童急性淋巴细胞白血病

2019-06-20

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：CTL019在复发性/难治性急性B淋巴细胞白血病和慢性淋巴细胞白血病中的细胞动力学分析。

2018-04-17

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

《中国成人急性淋巴细胞白血病诊断与治疗的指南（2016版）》解读

2018-07-01

科室
- - 订阅+
  - 更多科室
工具
服务